Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains
Reference (51)
- et al.
Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease
Neurosci. Lett.
(1987) - et al.
Decreased densities of dopamine D1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type
Brain Res.
(1988) - et al.
VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type
Neurobiol. Aging
(1988) - et al.
Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease
Brain Res.
(1986) - et al.
Loss of cannabinoid receptors in the substantia nigra in Huntington's disease
Neuroscience
(1993) - et al.
The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain
Neuroscience
(1985) - et al.
Amyloid deposition as the central event in the aetiology of Alzheimer's disease
Trends pharmac. Sci.
(1991) - et al.
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Brain Res.
(1991) - et al.
Selective reduction of [125I]apamin binding sites in Alzheimer hippocampus: a quantitative autoradiographic study
Brain Res.
(1991) - et al.
Alzheimer's disease: changes in hippocampal n-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study
Neuroscience
(1990)
Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides
Neurosci. Lett.
Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry
Neuroscience
Neurotransmitters and neuropeptides in Alzheimer's disease
Psychiat. Clin. N. Am.
Marijuana: acute effects on human memory
Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study
Brain Res.
Basal ganglia
Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease
Eur. Neurol.
Pathology of Alzheimer's disease
Psychiat. Clin. N. Am.
Alzheimer's plaques and tangles: a controlled and enhanced silver staining method
Soc. Neurosci. Abstr.
Interconnections between the corpus striatum and brain stem nuclei
Structure of the Human Brain: A Photographic Atlas
Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease
Ann. Neurol.
5-HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus
J. neural Transm. Park. Dis. Dement. Sec.
Cannabinoid pharmacology
Pharmac. Rev.
Cited by (239)
Women are taking the hit: Examining the unique consequences of cannabis use across the female lifespan
2023, Frontiers in NeuroendocrinologyCannabinoids and endocannabinoid signaling at the basal forebrain cholinergic system
2023, Cannabis Use, Neurobiology, Psychology, and TreatmentEndocannabinoid system reactivity during stress processing in healthy humans
2022, Biological PsychologyCitation Excerpt :With regard to the neurobiology of stress, neuroimaging studies in humans have identified several brain regions, which are primarily involved in the processing of stress and emotion regulation, namely the ventromedial prefrontal cortex (vmPFC), the amygdala and the hippocampus (Duval, Javanbakht, & Liberzon, 2015; Etkin, Egner, & Kalisch, 2011; Gramsch et al., 2014). Interestingly, these brain regions are also known to have a high endocannabinoid (eCB) receptor density (Glass et al., 1997; Westlake et al., 1994). Animal research suggests that the endocannabinoid system (ECS) with its two main eCBs anandamide (AEA) and 2-arachidonoylglycerol (2-AG) comes into play at the point of termination of the initial phase of the stress response mediated by the HPA-axis (Gray et al., 2015).
Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands
2022, Pharmacology Biochemistry and BehaviorParkinson's disease related alterations in cannabinoid transmission
2022, Brain Research Bulletin
- ‡
Present address: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, U.S.A.